Cellbricks Therapeutics
Pre-clinicalA tissue therapeutics company – built on DeepTech innovation – offering a scalable solution to restore lost tissue and organ function for millions of patients.
Founded
2020
Focus
Cell & Gene Therapy
About
A tissue therapeutics company – built on DeepTech innovation – offering a scalable solution to restore lost tissue and organ function for millions of patients.
Funding History
2Total raised: $11.3M
Series A$8.5MMIG CapitalMar 15, 2023
Seed$2.8MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile